Novo Nordisk Investigational Site

Wilmington, North Carolina 28401

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Endocrinology Clinical Trial
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Wilmington, NC
Click here to add this to my saved trials